INTRODUCTION AND AIMS: Use of Decision Making Tools (DMTs) facilitates an optimal modality information process and increases peritoneal dialysis (PD) incidence. However, other factors may contribute to PD take-on. Objectives: To analyze the impact of clinic PD experience on PD take-on in patients (pts) receiving a structured modality information program with the use of DMTs.

METHODS:Observational, prospective, open and international registry. All predialysis CKD G4-G5 pts and pts after an unplanned dialysis start (if non-informed before) were recruited to undergo a DMTs process for renal replacement therapy (RRT) choice, including personal values evaluation, RRT information with different aids, staff deliberation support and patient modality election. Clinics with ≥ 15 continuous annual prevalent PD pts (more experienced) were compared with clinics with 0-14 prevalent PD pts (less experienced).

RESULTS: 1934 pts from in total 49 clinics (cl) in Poland (987 pts, 19 cl), Hungary (338 pts, 10 cl), Romania (311 pts, 12 cl), Germany (259 pts, 7 cl), and Argentina (39 pts, 1 cl) aimed modality information between Aug 2014-June 2017. Large differences were observed between more PD-experienced clinics in PD choice (55%) and PD take-on (49%) and less PD-experienced clinics (14% and 12%, respectively), despite a similar use of DMT kits (more results in table).

CONCLUSIONS: Use of DMTs facilitates patient empowerment but its impact on PD choice and take-on is reduced in clinics with less experience of the technique.

Results comparison: more experienced PD clinics vs. less experienced

TotalClinics 0-14 pts.Clinics ≥15 pts.p value
Clinics (n)493415
Total (n)19341138796
Mean age (y.)61.264.759.80.02
PD contraindicated (%)2937180.00
HD/PD candidates (n)1377717652
Mean age (y.)60.263.159.40.00
Early referral (≥3m.) %5247570.15
DMTs kit use (%)9394920.57
Home orientation (%)4427630.00
PD choice (%)3314550.00
PD 1st sesión (%)219340.00
PD chronic (%)2912490.00
TotalClinics 0-14 pts.Clinics ≥15 pts.p value
Clinics (n)493415
Total (n)19341138796
Mean age (y.)61.264.759.80.02
PD contraindicated (%)2937180.00
HD/PD candidates (n)1377717652
Mean age (y.)60.263.159.40.00
Early referral (≥3m.) %5247570.15
DMTs kit use (%)9394920.57
Home orientation (%)4427630.00
PD choice (%)3314550.00
PD 1st sesión (%)219340.00
PD chronic (%)2912490.00

Results comparison: more experienced PD clinics vs. less experienced

TotalClinics 0-14 pts.Clinics ≥15 pts.p value
Clinics (n)493415
Total (n)19341138796
Mean age (y.)61.264.759.80.02
PD contraindicated (%)2937180.00
HD/PD candidates (n)1377717652
Mean age (y.)60.263.159.40.00
Early referral (≥3m.) %5247570.15
DMTs kit use (%)9394920.57
Home orientation (%)4427630.00
PD choice (%)3314550.00
PD 1st sesión (%)219340.00
PD chronic (%)2912490.00
TotalClinics 0-14 pts.Clinics ≥15 pts.p value
Clinics (n)493415
Total (n)19341138796
Mean age (y.)61.264.759.80.02
PD contraindicated (%)2937180.00
HD/PD candidates (n)1377717652
Mean age (y.)60.263.159.40.00
Early referral (≥3m.) %5247570.15
DMTs kit use (%)9394920.57
Home orientation (%)4427630.00
PD choice (%)3314550.00
PD 1st sesión (%)219340.00
PD chronic (%)2912490.00

This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://dbpia.nl.go.kr/journals/pages/about_us/legal/notices)

Comments

0 Comments
Submit a comment
You have entered an invalid code
Thank you for submitting a comment on this article. Your comment will be reviewed and published at the journal's discretion. Please check for further notifications by email.